MedicalSentry

Health Research Company

methylphenidate hydrochloride

generic name is methylphenidate hydrochloride

Why is this drug subscribed ?

Methylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children. Methylphenidate (Ritalin, Ritalin SR, Methylin, Methylin ER) is also used to treat narcolepsy (a sleep disorder that causes excessive daytime sleepiness and sudden attacks of sleep). Methylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by changing the amounts of certain natural substances in the brain.

Active Substance: METHYLPHENIDATE HYDROCHLORIDE

methylphenidate hydrochloride Available Drugs :

methylphenidate hydrochloride ndc# 0591-2715

by Watson Pharmaceuticals

ORAL TABLET with active strength of 18 mg/1

started marketing at 01/04/2011 .

methylphenidate hydrochloride ndc# 0591-2717

by Watson Pharmaceuticals

ORAL TABLET with active strength of 36 mg/1

started marketing at 01/04/2011 .

methylphenidate hydrochloride ndc# 0591-2716

by Watson Pharmaceuticals

ORAL TABLET with active strength of 27 mg/1

started marketing at 01/04/2011 .

methylphenidate hydrochloride ndc# 0591-2718

by Watson Pharmaceuticals

ORAL TABLET with active strength of 54 mg/1

started marketing at 01/04/2011 .

Methylphenidate Hydrochloride ndc# 67767-200

by Actavis South Atlantic LLC

ORAL CAPSULE, EXTENDED RELEASE with active strength of 20 mg/1

started marketing at 03/01/2012 .

Methylphenidate Hydrochloride ndc# 67767-201

by Actavis South Atlantic LLC

ORAL CAPSULE, EXTENDED RELEASE with active strength of 30 mg/1

started marketing at 03/01/2012 .

Methylphenidate Hydrochloride ndc# 67767-202

by Actavis South Atlantic LLC

ORAL CAPSULE, EXTENDED RELEASE with active strength of 40 mg/1

started marketing at 03/01/2012 .

Methylphenidate Hydrochloride ndc# 27808-058

by Tris Pharma, Inc.

ORAL SOLUTION with active strength of 5 mg/5mL

started marketing at 23/07/2010 .

Methylphenidate Hydrochloride ndc# 27808-059

by Tris Pharma, Inc.

ORAL SOLUTION with active strength of 10 mg/5mL

started marketing at 23/07/2010 .

Methylphenidate Hydrochloride ndc# 51991-713

by Breckenridge Pharmaceutical, Inc.

ORAL SOLUTION with active strength of 10 mg/5mL

started marketing at 01/07/2010 .

Methylphenidate Hydrochloride ndc# 51991-712

by Breckenridge Pharmaceutical, Inc.

ORAL SOLUTION with active strength of 5 mg/5mL

started marketing at 01/07/2010 .

Methylphenidate Hydrochloride ndc# 54868-6262

by Physicians Total Care, Inc.

ORAL TABLET with active strength of 27 mg/1

started marketing at 01/06/2011 .

Methylphenidate Hydrochloride ndc# 54868-6261

by Physicians Total Care, Inc.

ORAL TABLET with active strength of 18 mg/1

started marketing at 01/06/2011 .

METHYLPHENIDATE HYDROCHLORIDE ndc# 49999-844

by Lake Erie Medical DBA Quality Care Products LLC

ORAL TABLET with active strength of 20 mg/1

started marketing at 15/09/2010 .

METHYLPHENIDATE HYDROCHLORIDE ndc# 57664-228

by Caraco Pharmaceutical Laboratories, Ltd.

ORAL TABLET with active strength of 5 mg/1

started marketing at 29/03/2012 .

METHYLPHENIDATE HYDROCHLORIDE ndc# 57664-229

by Caraco Pharmaceutical Laboratories, Ltd.

ORAL TABLET with active strength of 10 mg/1

started marketing at 29/03/2012 .

METHYLPHENIDATE HYDROCHLORIDE ndc# 57664-230

by Caraco Pharmaceutical Laboratories, Ltd.

ORAL TABLET with active strength of 20 mg/1

started marketing at 29/03/2012 .

METHYLPHENIDATE HYDROCHLORIDE ndc# 63629-3279

by bryant ranch prepack

ORAL TABLET with active strength of 10 mg/1

started marketing at 01/02/2010 .

Methylphenidate Hydrochloride ndc# 63629-3166

by Bryant Ranch Prepack

ORAL TABLET with active strength of 20 mg/1

started marketing at 31/12/1955 .

Methylphenidate Hydrochloride ndc# 53014-532

by UCB Manufacturing, Inc.

ORAL TABLET with active strength of 20 mg/1

started marketing at 04/04/1979 .

Methylphenidate Hydrochloride ndc# 53014-531

by UCB Manufacturing, Inc.

ORAL TABLET with active strength of 5 mg/1

started marketing at 04/04/1979 .

Methylphenidate Hydrochloride ndc# 53014-530

by UCB Manufacturing, Inc.

ORAL TABLET with active strength of 10 mg/1

started marketing at 23/12/1977 .

Methylphenidate Hydrochloride ndc# 0406-1473

by Mallinckrodt, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 20 mg/1

started marketing at 18/03/2011 .

Methylphenidate Hydrochloride ndc# 0406-1445

by Mallinckrodt, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 10 mg/1

started marketing at 18/03/2011 .

Methylphenidate Hydrochloride ndc# 0406-1142

by Mallinckrodt, Inc.

ORAL TABLET with active strength of 5 mg/1

started marketing at 18/03/2011 .

Methylphenidate Hydrochloride ndc# 0406-1144

by Mallinckrodt, Inc.

ORAL TABLET with active strength of 10 mg/1

started marketing at 18/03/2011 .

Methylphenidate Hydrochloride ndc# 0406-1146

by Mallinckrodt, Inc.

ORAL TABLET with active strength of 20 mg/1

started marketing at 18/03/2011 .

Methylphenidate Hydrochloride ndc# 0781-5754

by Sandoz Inc

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 20 mg/1

started marketing at 31/03/1982 .

Methylphenidate Hydrochloride ndc# 0781-5753

by Sandoz Inc

ORAL TABLET with active strength of 20 mg/1

started marketing at 31/12/1955 .

Methylphenidate Hydrochloride ndc# 0781-5748

by Sandoz Inc

ORAL TABLET with active strength of 5 mg/1

started marketing at 31/12/1955 .

Methylphenidate Hydrochloride ndc# 0781-5749

by Sandoz Inc

ORAL TABLET with active strength of 10 mg/1

started marketing at 31/12/1955 .

Methylphenidate Hydrochloride ndc# 54868-3454

by Physicians Total Care, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 20 mg/1

started marketing at 16/12/1994 .

Methylphenidate Hydrochloride ndc# 60429-580

by Golden State Medical Supply, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 20 mg/1

started marketing at 20/05/2010 .

Methylphenidate Hydrochloride ndc# 60429-577

by Golden State Medical Supply, Inc.

ORAL TABLET with active strength of 10 mg/1

started marketing at 20/05/2010 .

Methylphenidate Hydrochloride ndc# 60429-576

by Golden State Medical Supply, Inc.

ORAL TABLET with active strength of 5 mg/1

started marketing at 20/05/2010 .

Methylphenidate Hydrochloride ndc# 60429-579

by Golden State Medical Supply, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 10 mg/1

started marketing at 20/05/2010 .

Methylphenidate Hydrochloride ndc# 60429-578

by Golden State Medical Supply, Inc.

ORAL TABLET with active strength of 20 mg/1

started marketing at 20/05/2010 .

Methylphenidate Hydrochloride ndc# 0093-5292

by Teva Pharmaceuticals USA Inc

ORAL CAPSULE, EXTENDED RELEASE with active strength of 50 mg/1

started marketing at 27/09/2012 .

Methylphenidate Hydrochloride ndc# 0093-5293

by Teva Pharmaceuticals USA Inc

ORAL CAPSULE, EXTENDED RELEASE with active strength of 60 mg/1

started marketing at 27/09/2012 .

Methylphenidate Hydrochloride ndc# 0093-5295

by Teva Pharmaceuticals USA Inc

ORAL CAPSULE, EXTENDED RELEASE with active strength of 10 mg/1

started marketing at 27/09/2012 .

Methylphenidate Hydrochloride ndc# 0093-5296

by Teva Pharmaceuticals USA Inc

ORAL CAPSULE, EXTENDED RELEASE with active strength of 20 mg/1

started marketing at 27/09/2012 .

Methylphenidate Hydrochloride ndc# 0093-5297

by Teva Pharmaceuticals USA Inc

ORAL CAPSULE, EXTENDED RELEASE with active strength of 30 mg/1

started marketing at 27/09/2012 .

Methylphenidate Hydrochloride ndc# 0093-5298

by Teva Pharmaceuticals USA Inc

ORAL CAPSULE, EXTENDED RELEASE with active strength of 40 mg/1

started marketing at 27/09/2012 .

Methylphenidate Hydrochloride ndc# 0093-5346

by Teva Pharmaceuticals USA Inc

ORAL CAPSULE, EXTENDED RELEASE with active strength of 20 mg/1

started marketing at 16/07/2012 .

Methylphenidate Hydrochloride ndc# 0093-5347

by Teva Pharmaceuticals USA Inc

ORAL CAPSULE, EXTENDED RELEASE with active strength of 30 mg/1

started marketing at 16/07/2012 .

Methylphenidate Hydrochloride ndc# 0093-5348

by Teva Pharmaceuticals USA Inc

ORAL CAPSULE, EXTENDED RELEASE with active strength of 40 mg/1

started marketing at 16/07/2012 .

methylphenidate hydrochloride Search Trends:

News :

Social Buzz

comments powered by Disqus